Corneal diseases are one of the leading causes of low vision and blindness throughout the world, which serves to increase visual disability among the young and working-age population. The low effectiveness of therapeutic treatment, lack of donor material and frequent rejection reactions after transplantation prompt the search for more effective methods of treating corneal diseases, both inflammatory and dystrophic.